SCHEMBL18796236

SCHEMBL18796236

Cc1ccc(Oc2nc3ccccc3nc2C)c(Br)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 3/20 0.44
▸ L3MBTL1 Q9Y468 5/20 0.43
▸ TSHR P16473 1/20 0.43
▸ MAPT P10636 6/20 0.42
▸ HPGD P15428 5/20 0.42
▸ TDP1 Q9NUW8 3/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ GAA P10253 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ PRKAG1 P54619 1/20 0.40
▸ PRKAA1 Q13131 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ PRKAB1 Q9Y478 1/20 0.40
▸ LCK P06239 1/20 0.39
▸ LMNA P02545 3/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18795957 0.85 NQO2 (0.50) NQO2L3MBTL1TSHRMAPTSMN1; SMN2
SCHEMBL18796232 0.85 POLB (0.42) NQO2L3MBTL1TSHRMAPTHPGD
SCHEMBL24287259 0.84 GAA (0.56) NQO2L3MBTL1TSHRMAPTHPGD
SCHEMBL18796404 0.83 LCK (0.52) NQO2L3MBTL1TSHRMAPTHPGD
SCHEMBL18796013 0.78 HTT (0.60) NQO2L3MBTL1MAPTHPGDTDP1
SCHEMBL18795994 0.76 MAPT (0.34) NQO2L3MBTL1TSHRMAPTHPGD
SCHEMBL18796028 0.76 SCD (0.43) NQO2L3MBTL1TSHRMAPTHPGD
SCHEMBL29287089 0.76 MAPT (0.43) NQO2L3MBTL1MAPTHPGDTDP1
SCHEMBL2400792 0.75 TDP1 (0.58) L3MBTL1TSHRMAPTHPGDTDP1
SCHEMBL30811086 0.75 TDP1 (0.58) L3MBTL1TSHRMAPTHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3368514-B1 TRISUBSTITUTED SILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AG (DE) 2021-08-18 — — EP disclosed
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-06-16 — — US disclosed
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-08-01 — — US disclosed
EP-3368514-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES Bayer CropScience Aktiengesellschaft (DE) 2018-09-05 — — EP disclosed
WO-2017072283-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-05-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues PIK3C3, ERG28, DDT NQO2 536/4885L3MBTL1 2453/4885TSHR 4289/4885
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES PIK3C3, ERG28, DDT NQO2 536/4885L3MBTL1 2453/4885TSHR 4289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback